drugset / Trial / NCT00293904

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

NCT00293904 ↗

Phase 1/2 Completed 36 enrolled Cytos Biotechnology AG
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate whether the use of a specific immunomodulatory principle (QbG10) together with conventional grass pollen allergen leads to a more rapid and more pronounced decrease of sensitivity against pollen than with the grass pollen allergen alone

Timeline

Start
2006-02
Primary completion
—
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CYT005-AllQbG10 Vaccine — —